AMERICAN INTERNATIONAL GROUP, INC. - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 1 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$86,000
-60.4%
17,229
+0.3%
0.00%
-100.0%
Q4 2020$217,000
+29.2%
17,184
+0.5%
0.00%0.0%
Q3 2020$168,000
-3.4%
17,103
-2.2%
0.00%0.0%
Q2 2020$174,000
+24.3%
17,492
+10.4%
0.00%0.0%
Q1 2020$140,000
+12.9%
15,850
+17.5%
0.00%
Q4 2019$124,000
+55.0%
13,490
-0.8%
0.00%
Q3 2019$80,000
-51.2%
13,603
-0.7%
0.00%
-100.0%
Q2 2019$164,0000.0%13,697
+0.9%
0.00%0.0%
Q1 2019$164,000
-6.8%
13,577
-3.1%
0.00%0.0%
Q4 2018$176,000
-16.2%
14,018
-0.8%
0.00%0.0%
Q3 2018$210,000
-9.9%
14,127
+1.9%
0.00%0.0%
Q2 2018$233,000
-11.1%
13,870
+21.1%
0.00%0.0%
Q1 2018$262,000
-16.0%
11,455
-5.1%
0.00%0.0%
Q4 2017$312,000
+76.3%
12,071
+0.5%
0.00%0.0%
Q3 2017$177,000
+14.2%
12,014
+8.1%
0.00%0.0%
Q2 2017$155,000
-10.4%
11,116
+9.5%
0.00%0.0%
Q1 2017$173,000
+76.5%
10,156
+7.1%
0.00%
Q4 2016$98,000
-99.9%
9,479
-0.3%
0.00%
Q3 2016$96,085,000
-9.8%
9,504
+0.1%
0.00%
Q2 2016$106,573,000
-13.4%
9,490
+5.4%
0.00%
Q1 2016$123,000,000
-28.1%
9,0070.0%0.00%
-100.0%
Q4 2015$171,000,000
+101083.4%
9,007
-0.2%
0.00%0.0%
Q3 2015$169,000
-99.9%
9,023
+0.1%
0.00%0.0%
Q2 2015$134,204,0009,0130.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
L1 Capital Pty Ltd 1,050,124$10,312,0003.31%
Alambic Investment Management, L.P. 19,934$196,0002.15%
INGALLS & SNYDER LLC 1,363,603$13,391,0000.92%
ACUTA CAPITAL PARTNERS, LLC 300,000$2,946,0000.80%
RA Capital Management 1,858,474$18,250,0000.33%
Perceptive Advisors 2,150,641$21,119,0000.31%
SPHERA FUNDS MANAGEMENT LTD. 310,000$3,044,0000.30%
Eversept Partners, LP 103,829$1,019,6010.23%
Opaleye Management Inc. 100,000$982,0000.19%
GSA CAPITAL PARTNERS LLP 58,095$570,0000.10%
View complete list of CONCERT PHARMACEUTICALS INC shareholders